Literature DB >> 26342626

Laboratory-induced stress and craving among individuals with prescription opioid dependence.

Sudie E Back1, Daniel F Gros2, Matthew Price3, Steve LaRowe2, Julianne Flanagan4, Kathleen T Brady2, Charles Davis4, Maryanne Jaconis4, Jenna L McCauley4.   

Abstract

BACKGROUND: Stress and conditioned drug cues have been implicated in the initiation, maintenance and relapse to substances of abuse. Although stress and drug cues are often encountered together, little research exists on whether stress potentiates the response to drug cues.
METHOD: Participants (N=75) were 39 community recruited individuals with current prescription opioid (PO) dependence and 36 healthy controls. Participants stayed overnight in the hospital for one night and then completed laboratory testing the following morning. During laboratory testing, participants were randomly assigned to a stress task (Trier Social Stress Task; TSST) or a no-stress condition. Following the stress manipulation, all participants completed a PO cue paradigm. Immediately before and after the stress and cue tasks, the following were assessed: subjective (stress, craving, anger, sadness, happiness), physiological (heart rate, blood pressure, galvanic skin response), and neuroendocrine responses (cortisol and dehydroepiandrosterone).
RESULTS: Internal validity of the stress task was demonstrated, as evidenced by significantly higher subjective stress, as well as cortisol, heart rate and blood pressure in the TSST compared to the no-stress group. Individuals with PO dependence evidenced significantly greater reactivity to the stress task than controls. Craving increased significantly in response to the drug cue task among PO participants. No stress×cue interaction was observed.
CONCLUSIONS: In this study, heightened stress reactivity was observed among individuals with PO dependence. Exposure to acute stress, however, did not potentiate craving in response to conditioned drug cues. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Cues; Opiates; Prescription opioids; Stress; Trier

Mesh:

Substances:

Year:  2015        PMID: 26342626      PMCID: PMC4582004          DOI: 10.1016/j.drugalcdep.2015.08.019

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  62 in total

1.  Mindfulness training modifies cognitive, affective, and physiological mechanisms implicated in alcohol dependence: results of a randomized controlled pilot trial.

Authors:  Eric L Garland; Susan A Gaylord; Charlotte A Boettiger; Matthew O Howard
Journal:  J Psychoactive Drugs       Date:  2010-06

2.  Conditioning factors in drug abuse: can they explain compulsion?

Authors:  C P O'Brien; A R Childress; R Ehrman; S J Robbins
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

3.  Stress-induced reinstatement of alcohol-seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429.

Authors:  Jesse R Schank; Charles L Pickens; Kelly E Rowe; Kejun Cheng; Annika Thorsell; Kenner C Rice; Yavin Shaham; Markus Heilig
Journal:  Psychopharmacology (Berl)       Date:  2011-02-22       Impact factor: 4.530

4.  The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting.

Authors:  C Kirschbaum; K M Pirke; D H Hellhammer
Journal:  Neuropsychobiology       Date:  1993       Impact factor: 2.328

5.  The effects of varenicline on stress-induced and cue-induced craving for cigarettes.

Authors:  Lara A Ray; Katy Lunny; Spencer Bujarski; Nathasha Moallem; Jennifer L Krull; Karen Miotto
Journal:  Drug Alcohol Depend       Date:  2013-01-05       Impact factor: 4.492

6.  Cigarette craving increases after a psychosocial stress test and is related to cortisol stress response but not to dependence scores in daily smokers.

Authors:  A F Buchmann; M Laucht; B Schmid; K Wiedemann; K Mann; U S Zimmermann
Journal:  J Psychopharmacol       Date:  2008-10-28       Impact factor: 4.153

7.  Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms.

Authors:  Xiu Liu; Friedbert Weiss
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

8.  Conditioned responses in a methadone population. A comparison of laboratory, clinic, and natural settings.

Authors:  A R Childress; A T McLellan; C P O'Brien
Journal:  J Subst Abuse Treat       Date:  1986

9.  Effects of gender and cigarette smoking on reactivity to psychological and pharmacological stress provocation.

Authors:  Sudie E Back; Angela E Waldrop; Michael E Saladin; Sharon D Yeatts; Annie Simpson; Aimee L McRae; Himanshu P Upadhyaya; Regana Contini Sisson; Eve G Spratt; Julia Allen; Mary Jeanne Kreek; Kathleen T Brady
Journal:  Psychoneuroendocrinology       Date:  2008-03-05       Impact factor: 4.905

Review 10.  Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine.

Authors:  K B Thor; M Kirby; L Viktrup
Journal:  Int J Clin Pract       Date:  2007-06-30       Impact factor: 2.503

View more
  22 in total

1.  Negative Affect-Related Factors Have the Strongest Association with Prescription Opioid Misuse in a Cross-Sectional Cohort of Patients with Chronic Pain.

Authors:  Gadi Gilam; John A Sturgeon; Dokyoung S You; Ajay D Wasan; Beth D Darnall; Sean C Mackey
Journal:  Pain Med       Date:  2020-02-01       Impact factor: 3.750

2.  Impact of early life adversity on the stress biobehavioral response during nicotine withdrawal.

Authors:  Mustafa al'Absi; Motohiro Nakajima; Andrine Lemieux
Journal:  Psychoneuroendocrinology       Date:  2018-08-15       Impact factor: 4.905

3.  Emotionally valenced stimuli impact response inhibition in those with substance use disorder and co-occurring anxiety and depression symptoms.

Authors:  Alison C Legrand; Matthew Price
Journal:  J Affect Disord       Date:  2020-02-03       Impact factor: 4.839

4.  Development of an integrated cognitive behavioral therapy for anxiety and opioid use disorder: Study protocol and methods.

Authors:  R Kathryn McHugh; Victoria R Votaw; David H Barlow; Garrett M Fitzmaurice; Shelly F Greenfield; Roger D Weiss
Journal:  Contemp Clin Trials       Date:  2017-07-08       Impact factor: 2.226

5.  Psycho-physiological response to pain among individuals with comorbid pain and opioid use disorder: Implications for patients with prolonged abstinence.

Authors:  Amy Wachholtz; Gerardo Gonzalez; Douglas Ziedonis
Journal:  Am J Drug Alcohol Abuse       Date:  2019-06-27       Impact factor: 3.829

6.  Gender differences in subjective stress and neuroendocrine response to a stress task among individuals with opioid dependence: A pilot study.

Authors:  Amanda K Gilmore; Constance Guille; Nathaniel L Baker; Kathleen T Brady; Christine K Hahn; Callah M Davis; Jenna L McCauley; Sudie E Back
Journal:  Addict Behav       Date:  2019-01-05       Impact factor: 3.913

Review 7.  The Opioid-Addicted Tetrapartite Synapse.

Authors:  Anna Kruyer; Vivian C Chioma; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2019-06-13       Impact factor: 13.382

8.  Exacerbated Craving in the Presence of Stress and Drug Cues in Drug-Dependent Patients.

Authors:  Kenzie L Preston; William J Kowalczyk; Karran A Phillips; Michelle L Jobes; Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; David H Epstein
Journal:  Neuropsychopharmacology       Date:  2017-11-06       Impact factor: 7.853

9.  Responses to social evaluative stress in regular cannabis smokers.

Authors:  Richard J Xia; Thomas Chao; Divya Patel; Gillinder Bedi
Journal:  J Psychopharmacol       Date:  2021-02-07       Impact factor: 4.153

Review 10.  Opioid Craving in Human Laboratory Settings: a Review of the Challenges and Limitations.

Authors:  Kimberly Goodyear; Carolina L Haass-Koffler
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.